How were Andromeda Metals' earnings last quarter?

Andromeda Metals Limited (ASX:ADN) issued its earnings results on Tuesday, March, 13th. The company reported $0.00 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Andromeda Metals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Andromeda Metals investors own include U.S. Silica (SLCA) , VanEck Bionic Engineering UCITS ETF A Acc (CYBG) and Alumina (AWC) .

ASX:ADN

Andromeda Metals (ADN) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free ADN Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 6.96 million shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 2.50%
Price Target: N/A

Stock Analysis

Get Andromeda Metals alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Andromeda Metals Stock (ASX:ADN)

Andromeda Metals Limited, together with its subsidiaries, operates as a mineral exploration company in Australia. It explores for halloysite, kaolin, gold, and copper deposits. The company's primary project is the Great White and Mount Hope Kaolin project located in the Eyre Peninsula in South Australia. It also holds interests in the Drummond Epithermal Gold Project located in Drummond Basin, North Queensland; and the Eyre Peninsula Gold, Eyre Kaolin Project, Camel Lake Halloysite Project, and Moonta Copper Gold Project located in South Australia. The company was formerly known as Adelaide Resources Limited and changed its name to Andromeda Metals Limited in December 2016. Andromeda Metals Limited was incorporated in 1993 and is headquartered in Adelaide, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

ADN Stock News Headlines

April 19, 2024 | msn.com

Andromeda expects 20% growth in loan disbursals; it aims for Rs 1 lakh crore in FY25

April 18, 2024 | msn.com

Andromeda sofas by LSM for UniFor

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

April 18, 2024 | msn.com

Andromeda coffee tables by LSM for UniFor

April 16, 2024 | msn.com

Andromeda tables by LSM for UniFor

April 15, 2024 | msn.com

Weyes Blood Celebrates ‘Titanic Rising' Anniversary With Stellar ‘Andromeda' Video

April 15, 2024 | msn.com

Weyes Blood Shares New Video for “Andromeda”: Watch

April 12, 2024 | msn.com

Andromeda credenza by LSM for UniFor

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 11, 2024 | thestreet.com

cheqd Teams Up With Andromeda & Devolved AI To Accelerate Growth In Trusted Data Markets

March 13, 2024 | finance.yahoo.com

When Can We Expect A Profit From Andromeda Metals Limited (ASX:ADN)?

February 23, 2024 | proactiveinvestors.com.au

Andromeda Metals CEO showcases Great White products to global buyers of kaolin for ceramics

February 16, 2024 | finance.yahoo.com

Andromeda Metals Limited (ADN.AX)

February 7, 2024 | msn.com

Andromeda galaxy has over 100 million suns. It will collide with the Milky Way

January 28, 2024 | forbes.com

Waning ‘Wolf Moon’ Reveals The Andromeda Galaxy: The Night Sky This Week

January 23, 2024 | investing.com

Andromeda Metals Ltd (ADN)

January 21, 2024 | msn.com

Hot Money Monday: Laramide, Andromeda, Cryosite are rising on momentum. Are they a buy?

January 10, 2024 | msn.com

This New Sci-FI RPG Might Achieve What Mass Effect Andromeda Couldn't

January 10, 2024 | theglobeandmail.com

Bitget Wallet Now Supports Metis Andromeda Mainnet

December 17, 2023 | au.investing.com

Andromeda Metals to sell Alford West tenement to EnviroCopper and retain royalties from operations

December 15, 2023 | news.yahoo.com

OTD In Space - December 15: Andromeda Galaxy Spotted By Telescope For The 1st Time

November 15, 2023 | au.investing.com

Andromeda Metals partners with Hallett Group for Great White HRM 'green cement' product

November 15, 2023 | proactiveinvestors.com.au

Andromeda Metals delivers maiden 53.5 million tonnes kaolin resource for Chairlift

November 14, 2023 | au.investing.com

Andromeda Metals boosts war chest by offloading non-core assets

November 8, 2023 | msn.com

BioWare is teasing Andromeda and OG trilogy connections in Mass Effect 5

October 17, 2023 | proactiveinvestors.com.au

Andromeda Metals signs binding kaolin offtake agreement for Chinese market

October 7, 2023 | msn.com

Mass Effect 4 Needs to Right One Wrong from Andromeda

See More Headlines

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Andromeda Metals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/13/2018
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
Sub-Industry: N/A
Current Symbol: ASX:ADN
CUSIP: N/A
CIK: N/A
Web: www.andromet.com.au
Phone: +61-8-82710600
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,560,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -5.88%
Return on Assets: -3.74%

Debt

Debt-to-Equity Ratio: 0.40
Current Ratio: 5.86
Quick Ratio: 14.60

Sales & Book Value

Annual Sales: $2 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 17.67
Book Value: A$0.05 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 3,110,000,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.30

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Robert Katsiouleris
MD, CEO & Director
Mr. Pascal Alexander-Bossy
Chief Financial Officer
Ms. Sarah Clarke
General Counsel & Company Secretary
Mr. Eric J. Whittaker
Chief Geologist

Key Competitors

View All Competitors

Insiders

ADN Stock Analysis - Frequently Asked Questions

How were Andromeda Metals' earnings last quarter?: Andromeda Metals Limited (ASX:ADN) issued its earnings results on Tuesday, March, 13th. The company reported $0.00 earnings per share (EPS) for the quarter.
What other stocks do shareholders of Andromeda Metals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Andromeda Metals investors own include U.S. Silica (SLCA), VanEck Bionic Engineering UCITS ETF A Acc (CYBG) and Alumina (AWC).

This page (ASX:ADN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial